Rambaldi A, Rossi V, Allavena P, Introna M, Landolfo S, Bassan R, Barbui T, Mantovani A
Scand J Immunol. 1986 Feb;23(2):183-8. doi: 10.1111/j.1365-3083.1986.tb01956.x.
We have studied five patients with chronic lymphocytosis consisting of large granular lymphocytes (LGL). The increased numbers of LGL in these patients had little or no natural killer activity, mediated antibody-dependent cellular cytotoxicity, and were induced to kill tumour lines after culture for 3 days with interleukin 2 (IL-2). Patients' LGL showed considerable reactivity with HNK-1 and AB8.28 monoclonal antibodies (MoAb), whereas positivity for OKM1 and N901 was found in only two subjects, and only one patient reacted with B73.1. No appreciable reactivity has been found with anti-Tac MoAb in the four patients tested. In the absence of stimulation, the patients' LGL produced no IL-2 and only minimal amounts of IL-1 and interferon (IFN). On stimulation with lipopolysaccharides (for IL-1) or phytohaemagglutinin A (PHA) (for IL-2 and IFN), they produced IL-1 and IFN in amounts similar to those produced by normal lymphocytes, but only modest levels of IL-2. These results indicated that proliferating LGL, like normal LGL, have a secretory capacity. The lack of constitutive lymphokine production, the lack of Tac receptor expression, and the defect in IL-2 production after PHA stimulation do not support the hypothesis of an autocrine proliferation sustained by a known growth factor.
我们研究了5例由大颗粒淋巴细胞(LGL)组成的慢性淋巴细胞增多症患者。这些患者中LGL数量增加,但自然杀伤活性很低或没有,介导抗体依赖性细胞毒性,并且在与白细胞介素2(IL-2)培养3天后被诱导杀伤肿瘤细胞系。患者的LGL与HNK-1和AB8.28单克隆抗体(MoAb)有相当的反应性,而仅在两名受试者中发现OKM1和N901呈阳性,并且只有一名患者与B73.1反应。在所测试的4例患者中,未发现与抗Tac MoAb有明显反应。在没有刺激的情况下,患者的LGL不产生IL-2,仅产生极少量的IL-1和干扰素(IFN)。在用脂多糖(用于IL-1)或植物血凝素A(PHA)(用于IL-2和IFN)刺激后,它们产生的IL-1和IFN量与正常淋巴细胞产生的量相似,但仅产生适度水平的IL-2。这些结果表明,增殖的LGL与正常LGL一样,具有分泌能力。组成性淋巴因子产生的缺乏、Tac受体表达的缺乏以及PHA刺激后IL-2产生的缺陷不支持由已知生长因子维持的自分泌增殖假说。